# PPI's and SSRI's Therapy for the Management of NCCP

> **NCT02825342** · PHASE4 · TERMINATED · sponsor: **Evangelismos Hospital** · enrollment: 60 (actual)

## Conditions studied

- Chest Pain Rule Out Myocardial Infarction

## Interventions

- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT02825342
- **Lead sponsor:** Evangelismos Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Primary endpoint was reached.
- **Last updated:** 2019-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02825342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02825342, "PPI's and SSRI's Therapy for the Management of NCCP". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02825342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*